BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35924408)

  • 1. Clonal evolution in hereditary thrombocytosis with MPL T487A mutation.
    Vasseur L; Favier R; Kim R; Rabian F; Cabannes-Hamy A; Cassinat B; Maslah N; Vasquez N; Clappier E; Kiladjian JJ; Boissel N
    Pediatr Blood Cancer; 2023 Feb; 70(2):e29905. PubMed ID: 35924408
    [No Abstract]   [Full Text] [Related]  

  • 2. Hereditary thrombocytosis: the genetic landscape.
    Han EY; Catherwood M; McMullin MF
    Br J Haematol; 2021 Sep; 194(6):1098-1105. PubMed ID: 34341988
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic workflow for hereditary erythrocytosis and thrombocytosis.
    McMullin MF
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):391-396. PubMed ID: 31808840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombocytosis.
    Skoda RC
    Hematology Am Soc Hematol Educ Program; 2009; ():159-67. PubMed ID: 20008195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary erythrocytosis, thrombocytosis and neutrophilia.
    Hong WJ; Gotlib J
    Best Pract Res Clin Haematol; 2014 Jun; 27(2):95-106. PubMed ID: 25189721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline MPL mutations may be a rare cause of "triple-negative" thrombocytosis.
    Borsani O; Pietra D; Casetti IC; Vanni D; Riccaboni G; Catricalà S; Grazia B; Boveri E; Arcaini L; Rumi E
    Exp Hematol; 2024 Jan; 129():104127. PubMed ID: 37939832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent
    Ye MT; Wang Y; Wang SA; Pemmaraju N; Daver N; Verstovsek S; Zhang Y; Zuo Z; Medeiros LJ; You MJ
    Leuk Lymphoma; 2020 Apr; 61(4):963-966. PubMed ID: 31750750
    [No Abstract]   [Full Text] [Related]  

  • 8. UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation.
    Szpurka H; Gondek LP; Mohan SR; Hsi ED; Theil KS; Maciejewski JP
    Leukemia; 2009 Mar; 23(3):610-4. PubMed ID: 18818701
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombopoietin Measurement as a Key Component in the Evaluation of Pediatric Thrombocytosis.
    Nelson ND; Marcogliese A; Bergstrom K; Scheurer M; Mahoney D; Bertuch AA
    Pediatr Blood Cancer; 2016 Aug; 63(8):1484-7. PubMed ID: 27100794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical course of myeloproliferative leukaemia virus oncogene (MPL) mutation-associated familial thrombocytosis: a review of 64 paediatric and adult patients.
    Al-Harbi T; Al-Zahrani M; Al-Balwi M; Al-Hazmi A; Alsuhaibani A; Aljafn N; Alsumari F; Aleshaiwi L; Alsuhibani A; Alqasim O; Ahmad N
    Br J Haematol; 2021 Sep; 194(5):893-898. PubMed ID: 34131895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexplained thrombocytosis: association of Baltimore polymorphism with germline MPL nonsense mutation.
    Verger E; Teillet F; Conejero C; Letort G; Chomienne C; Giraudier S; Cassinat B
    Br J Haematol; 2016 Oct; 175(1):167-9. PubMed ID: 26568271
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia.
    Liu K; Martini M; Rocca B; Amos CI; Teofili L; Giona F; Ding J; Komatsu H; Larocca LM; Skoda RC
    Haematologica; 2009 Oct; 94(10):1368-74. PubMed ID: 19608689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin receptor activation, thrombopoietin mimetic drugs, and hereditary thrombocytosis: remarks on bone marrow fibrosis.
    Teofili L; Giona F; Martini M; Torti L; Cenci T; Foà R; Leone G; Larocca LM
    J Clin Oncol; 2010 Jul; 28(19):e317-8. PubMed ID: 20516451
    [No Abstract]   [Full Text] [Related]  

  • 14. MPL Baltimore mutation and thrombocytosis: case report and literature review.
    Shkalim-Zemer V; Dgany O; Krasnov T; Yacobovich J; Tamary H
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):e112-4. PubMed ID: 23511495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis.
    Marty C; Pecquet C; Nivarthi H; El-Khoury M; Chachoua I; Tulliez M; Villeval JL; Raslova H; Kralovics R; Constantinescu SN; Plo I; Vainchenker W
    Blood; 2016 Mar; 127(10):1317-24. PubMed ID: 26608331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The S505A thrombopoietin receptor mutation in childhood hereditary thrombocytosis and essential thrombocythemia is S505N: single letter amino acid code matters.
    Defour JP; Levy G; Leroy E; Smith SO; Constantinescu SN
    Leukemia; 2019 Feb; 33(2):563-564. PubMed ID: 30635630
    [No Abstract]   [Full Text] [Related]  

  • 17. Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis.
    Teofili L; Giona F; Torti L; Cenci T; Ricerca BM; Rumi C; Nunes V; Foà R; Leone G; Martini M; Larocca LM
    Haematologica; 2010 Jan; 95(1):65-70. PubMed ID: 19713221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial thrombocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL gene.
    El-Harith el-HA; Roesl C; Ballmaier M; Germeshausen M; Frye-Boukhriss H; von Neuhoff N; Becker C; Nürnberg G; Nürnberg P; Ahmed MA; Hübener J; Schmidtke J; Welte K; Stuhrmann M
    Br J Haematol; 2009 Jan; 144(2):185-94. PubMed ID: 19036112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CALR mutants causes mpl-dependent thrombocytosis in zebrafish.
    Lim KH; Chang YC; Chiang YH; Lin HC; Chang CY; Lin CS; Huang L; Wang WT; Gon-Shen Chen C; Chou WC; Kuo YY
    Blood Cancer J; 2016 Oct; 6(10):e481. PubMed ID: 27716741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomics of clonal evolution in a rare essential thrombocythemia with coexisting Type 2 CALR and MPL S204P mutations.
    Wang J; Fu W; Bao W; Gong W; Xu S; Ling C; Jin Q; Zhang Q
    Platelets; 2023 Dec; 34(1):2176167. PubMed ID: 36786035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.